
Our partner Evnia submitted an abstract and represented the consortium at the 34th Alzheimer Europe Conference in Geneva, Switzerland, held from October 8-10, 2024. The conference provided a great opportunity to present the initial results of our exploratory studies, which are shaping the design of the 2D-BioPAD system.
The conference attracted a wide range of attendees, including researchers, healthcare professionals, patients and caregivers, and private companies. Evnia’s presence helped increase awareness of the 2D-BioPAD project, allowing for valuable conversations and connections with these key groups.
For further details regarding the conference, you may review the key highlights from Day 1, Day 2, and Day 3.